Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in the treatment of hypertension: Adding more fuel for the fire?

被引:2
作者
Fontes-Carvalho, Ricardo [1 ,2 ]
机构
[1] Ctr Hosp Gaia, Dept Cardiol, Vila Nova De Gaia, Portugal
[2] Univ Porto, Dept Physiol & Cardiothorac Surg, Cardiovasc Res Dev Unit, Fac Med, Al Prof Hernani Monteiro, P-4200319 Oporto, Portugal
关键词
METAANALYSIS; RISK;
D O I
10.1177/2047487317739052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1911 / 1913
页数:3
相关论文
共 13 条
[1]  
Angiotensin converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers, 2017, EUR J PREV CARDIOL, V24, P1914
[2]  
Baker WL, 2009, ANN INTERN MED, V151, P861, DOI [10.7326/0000605-200912150-00162, 10.7326/0003-4819-151-12-200912150-00162]
[3]  
Barnett AH, 2014, NEW ENGL J MED, V351, P1952
[4]  
BIKDELI B, 2017, J AM HEART ASSOC, V6
[5]   Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE [J].
Ceconi, Claudio ;
Francolini, Gloria ;
Olivares, Adriana ;
Comini, Laura ;
Bachetti, Tiziana ;
Ferrari, Roberto .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 577 (1-3) :1-6
[6]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360
[7]   Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies [J].
Hao, Guang ;
Wang, Zengwu ;
Guo, Rui ;
Chen, Zuo ;
Wang, Xin ;
Zhang, Linfeng ;
Li, Wei .
BMC CARDIOVASCULAR DISORDERS, 2014, 14
[8]  
Lancet Editors, 2013, Lancet, V382, P843, DOI 10.1016/S0140-6736(13)61847-4
[9]   Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies [J].
Law, M. R. ;
Morris, J. K. ;
Wald, N. J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1245
[10]   2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) [J].
Piepoli, Massimo F. ;
Hoes, Arno W. ;
Agewall, Stefan ;
Albus, Christian ;
Brotons, Carlos ;
Catapano, Alberico L. ;
Cooney, Marie-Therese ;
Corra, Ugo ;
Cosyns, Bernard ;
Deaton, Christi ;
Graham, Ian ;
Hall, Michael Stephen ;
Hobbs, F. D. Richard ;
Lochen, Maja-Lisa ;
Loellgen, Herbert ;
Marques-Vidal, Pedro ;
Perk, Joep ;
Prescott, Eva ;
Redon, Josep ;
Richter, Dimitrios J. ;
Sattar, Naveed ;
Smulders, Yvo ;
Tiberi, Monica ;
van der Worp, H. Bart ;
van Dis, Ineke ;
Verschuren, W. M. Monique ;
De Backer, Guy ;
Roffi, Marco ;
Aboyans, Victor ;
Bachl, Norbert ;
Bueno, Hector ;
Carerj, Scipione ;
Cho, Leslie ;
Cox, John ;
De Sutter, Johan ;
Egidi, Guenther ;
Fisher, Miles ;
Fitzsimons, Donna ;
Franco, Oscar H. ;
Guenoun, Maxime ;
Jennings, Catriona ;
Jug, Borut ;
Kirchhof, Paulus ;
Kotseva, Kornelia ;
Lip, Gregory Y. H. ;
Mach, Francois ;
Mancia, Giuseppe ;
Bermudo, Franz Martin ;
Mezzani, Alessandro ;
Niessner, Alexander .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (11) :NP1-NP96